Pharmaceutical Industry
HealthEU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021
By Timothy Annett and BloombergDecember 20, 2021
Health‘Pharma Bro’ drugmaker will pay up to $40 million to settle case over jacking up medicine price by 4,000%
By The Associated PressDecember 8, 2021
MagazineInsulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
By Geoff ColvinDecember 6, 2021
CommentaryIf we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
By Mark Dybul and Serhat GümrükçüDecember 1, 2021
By Nicole Hassoun and Kaushik BasuNovember 29, 2021
By Michelle McMurry-Heath and Henry SkinnerNovember 25, 2021
FeaturesRiding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead
By Erika FryOctober 30, 2021
By David MeyerOctober 27, 2021
By Matthew Perrone and The Associated PressOctober 11, 2021
Most Popular
